HYDROMATRIX — 1503461
Numéro de demande
1503461
Numéro d'enregistrement
TMA856904
Type(s)
Mot
Catégorie
Marque de commerce
Statut de l'OPIC
REGISTERED
Statut de TM5
ACTIF/ENREGISTREMENT/
émit et actif
La demande de marque a été enregistrée auprès de l’Office.
Produite
2010-11-12
Enregistrée
2013-08-02
Date d’expiration de l’enregistrement
2028-08-02
Propriétaire inscrit
ORX PHARMACEUTICAL CORPORATION
55 Town Centre Court
Suite 800
Toronto
ONTARIO M1P4X4
Documents
Rubriques d'index
- HYDROMATRIX
- HYDRO MATRIX
Produits (Classe de Nice & Énoncé(s))
- (1) Tablets and capsules used to administer orally ingestible controlled release pharmaceuticals. A typical tablet contains at least an active drug in intimate mixture with a least two pharmaceutical polymers. The essential feature is the utility of novel hydrostatic couple compositions acting in tandem to induce hydrostatic pressure within a matrix solid dosage form such as a tablet or pellet. This novel concept is based on the effect of a hydrostatic pressure modulating polymers within the core of the solid dosage form in which differential hydrostatic pressure is created by the interaction between two polymers (hydrostatic couple) produces a release controlling pressure for zero-order release of the active ingredient. The understanding and controlling of properties associated with the hydrostatic couple facilitates time-release delivery of a wide range of pharmaceuticals. This solid composition accommodates oral control release of a wide range of drugs and beneficial agents whose kinetics are usually difficult to control and deliver due to high drug loading and highly solubility. This oral solid composition is based on the active drug being embedded in a homogeneous mixture of two or more polymers referred as the hydrostatic couple components. Formulations can also be programmed to delay onset of drug release as well as deliver multiple drugs at different rates simultaneously. This oral solid composition is simple to implement, easy to scale-up, inexpensive and offers numerous advantages over other technologies geared towards similar goals.
Information relative de classification
Mise en garde
Les données relatives à la classification sont fournies à des fins d’information et de recherche seulement. L’OPIC ne garantit pas l’exactitude des classes attribuées à la marque de commerce. Ces données n’ont aucune valeur juridique.
- 5 - Pharmaceutiques et herbicides
Revendication(s)
- Declaration of Use filed August 02, 2013
Historique des actions
| Action | Date de l'action | Date d'échéance | Commentaires |
|---|---|---|---|
| Produite | 2010-11-12 | ||
| Créé | 2010-11-12 | ||
| Formalisée | 2010-11-19 | ||
| Recherche enregistrée | 2011-03-28 | ||
| Premier rapport de l'examinateur | 2011-03-28 | 2011-09-28 | |
| Correspondance créée | 2011-07-14 | 2012-01-14 | |
| Correspondance créée | 2012-02-23 | 2012-08-23 | |
| Correspondance créée | 2012-05-03 | 2012-11-03 | |
| Avis d'approbation envoyé | 2012-11-05 | 2012-12-03 | |
| Approuvée | 2012-12-27 | APPROVED BY PROGRAM EX200M1 | |
| Publiée | 2013-01-16 | Vol.60 Issue 3038 | |
| Admise | 2013-05-03 | ||
| Avis d'admission envoyé | 2013-05-03 | 2013-11-12 | |
| Enregistrée | 2013-08-02 | 2028-08-02 |